Related Experiment Video
Updated: Mar 25, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Unveiling new chemical scaffolds as Mnk inhibitors
Sarah Diab1, Peng Li1, Sunita K C Basnet1
1Centre for Drug Discovery & Development, Sansom Institute for Health Research, Centre for Cancer Biology, School of Pharmacy & Medical Sciences, University of South Australia, Adelaide, South Australia 5001, Australia.
Abstract:
The discovery of small molecules that selectively inhibit Mnks is considered of paramount importance towards deciphering the exact role of these proteins in carcinogenesis and to further validate them as anti-cancer drug targets. However, the dearth of structural information of Mnks is a major hurdle. This study unveils the 7H-pyrrolo[2,3-d]pyrimidine derivatives as potent inhibitors of Mnks. ATP and substrate competition assays showed that this scaffold interacts with the ATP binding site, but not with the substrate site. Screened against a panel of cancer cells, Mnk inhibitors were most potent against MV4-11 acute myeloid leukemia cells. The induction of apoptosis was shown to be mediated by downregulation of Mcl-1.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
Inhibition of CDK Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Microtubule Associated Proteins (MAPs)

